H.R. 2379 117th Congress
State Opioid Response Grant Authorization Act of 2021
Latest action, Oct 21, 2021: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
How the House voted: On Motion to Suspend the Rules and Pass, as Amended
Oct 20, 2021 · Passed · 380–46 (it needed 2/3)
- Yea (380)
- Nay (46)
- Didn't vote (5)
- Letters: party (D, R, I)
By party
- Democrat
- Republican
- Independent
8 cosponsors
Sponsored by David J. Trone (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
3 D · 5 R
- Democrat
- Republican
- Independent
Referred to: Senate: Health, Education, Labor, and Pensions Committee; House: Energy and Commerce Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
EMERGENT BIOSOLUTIONS
ALPINE GROUP PARTNERS, LLC.
8 reports
EMERGENT BIOSOLUTIONS
FORBES-TATE
8 reports
8 reports
EMERGENT BIOSOLUTIONS INC.
NAVIGATORS GLOBAL LLC (FORMERLY DC NAVIGATORS, LLC)
8 reports
AMERICAN PROPERTY CASUALTY INSURANCE ASSOCIATION
AMERICAN PROPERTY CASUALTY INSURANCE ASSOCIATION FKA PROPERTY CASUALTY INSURERS ASSOC. OF AMERICA
7 reports
7 reports
EMERGENT BIOSOLUTIONS
HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC
7 reports
EMERGENT BIOSOLUTIONS INC.
ERVIN GRAVES STRATEGY GROUP, LLC
7 reports
EMERGENT BIOSOLUTIONS INC.
THE OB-C GROUP, LLC
7 reports
EMERGENT BIOSOLUTIONS
DOTCHIN & ASSOCIATES, LLC
4 reports
EMERGENT BIOSOLUTIONS INC.
BLANK ROME GOVERNMENT RELATIONS
4 reports
2 reports
2 reports
EMERGENT BIOSOLUTIONS INC
MERCURY PUBLIC AFFAIRS, LLC
1 report
1 report
All 15 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | House |
|---|---|---|---|---|---|---|
| EMERGENT BIOSOLUTIONS | ALPINE GROUP PARTNERS, LLC. | 8 | $0 | Q1 2021 | Q3 2022 | yes |
| EMERGENT BIOSOLUTIONS | FORBES-TATE | 8 | $0 | Q1 2021 | Q3 2022 | yes |
| EMERGENT BIOSOLUTIONS INC | 8 | $5.9M | Q1 2021 | Q3 2022 | yes | |
| EMERGENT BIOSOLUTIONS INC. | NAVIGATORS GLOBAL LLC (FORMERLY DC NAVIGATORS, LLC) | 8 | $0 | Q1 2021 | Q3 2022 | yes |
| AMERICAN PROPERTY CASUALTY INSURANCE ASSOCIATION | AMERICAN PROPERTY CASUALTY INSURANCE ASSOCIATION FKA PROPERTY CASUALTY INSURERS ASSOC. OF AMERICA | 7 | $10.1M | Q4 2021 | Q3 2022 | yes |
| AMERICAN PROPERTY CASUALTY INSURANCE ASSOCIATION FKA PROPERTY CASUALTY INSURERS | CGCN GROUP, LLC | 7 | $294K | Q4 2021 | Q3 2022 | yes |
| EMERGENT BIOSOLUTIONS | HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC | 7 | $0 | Q4 2021 | Q3 2022 | yes |
| EMERGENT BIOSOLUTIONS INC. | ERVIN GRAVES STRATEGY GROUP, LLC | 7 | $0 | Q1 2021 | Q3 2022 | yes |
| EMERGENT BIOSOLUTIONS INC. | THE OB-C GROUP, LLC | 7 | $0 | Q1 2021 | Q3 2022 | yes |
| EMERGENT BIOSOLUTIONS | DOTCHIN & ASSOCIATES, LLC | 4 | $0 | Q1 2021 | Q3 2021 | yes |
| EMERGENT BIOSOLUTIONS INC. | BLANK ROME GOVERNMENT RELATIONS | 4 | $0 | Q1 2021 | Q3 2021 | yes |
| AMERICAN PSYCHIATRIC ASSOCIATION | 2 | $320K | Q4 2021 | Q3 2021 | yes | |
| VITAS HEALTHCARE CORPORATION | 2 | $490K | Q4 2022 | Q3 2022 | yes | |
| EMERGENT BIOSOLUTIONS INC | MERCURY PUBLIC AFFAIRS, LLC | 1 | $0 | Q3 2021 | Q3 2021 | yes |
| HOSPICE ACTION NETWORK | 1 | $280K | Q3 2022 | Q3 2022 | yes |